Imexpharm Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was VND 439,691.31 million compared to VND 354,451.56 million a year ago. Net income was VND 79,675.42 million compared to VND 46,612.12 million a year ago. Basic earnings per share from continuing operations was VND 967.619 compared to VND 565.7143 a year ago.
For the six months, revenue was VND 918,963.36 million compared to VND 668,696.76 million a year ago. Net income was VND 157,501.72 million compared to VND 99,213.42 million a year ago. Basic earnings per share from continuing operations was VND 1,912.381 compared to VND 1,204.7619 a year ago.